News

Gene Therapy

Inhibitor Development in Gene Therapy for Haemophilia

Read More »

June 2, 2026

E-Learning

Module 23: Bleeding disorder of unknown cause & Ultra-Rare Bleeding Disorders

Read More »

May 10, 2026

E-Learning

Module 22: Connecting the Dots: How Hemophilia Guidelines Drive Practice, Policy, and Access

Read More »

April 10, 2026

E-Learning

Revisiting the role of FVIII in Haemophilia A in 2026

Read More »

March 30, 2026

Gene Therapy

Webinar: Clinical Implications of Roctavian’s Market Withdrawal

Read More »

March 17, 2026

Executive Committee

Leading the Future of EAHAD: Ana Boban, EAHAD President 2026-2028

Read More »

March 3, 2026

Psycosocial Professionals

Call for Applications: EAHAD Psychosocial Professionals Committee

Read More »

February 24, 2026

Congress

EAHAD 2026 Congress Press Release

Read More »

February 23, 2026

E-Learning

Module 21: When to consider Ehlers-Danlos Syndromes in a patient with haemorrhagic symptoms

Read More »

January 12, 2026

E-Learning

Module 20: Heavy Menstrual Bleeding in Women with VRCFD

Read More »

November 24, 2025

E-Learning

Module 19: Glanzmann Thrombasthenia

Read More »

October 13, 2025

Generic

Memorandum of Understanding (MoU) with WFH

Read More »

October 4, 2025